Telomir Pharmaceuticals
TELO
#10411
Rank
A$63.98 M
Marketcap
A$0.87
Share price
4.00%
Change (1 day)
-58.57%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Telomir Pharmaceuticals CIK: 0001971532

Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q3

10-Q Quarterly Report FY2026 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q2

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q1

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q3

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q2

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q1

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q3

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q2

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q1

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)